Performance analysis of Sigilon Therapeutics (SGTX)
Annual Return
Over the past 3 years, SGTX has had an average annual return of +423.16%, outperforming the benchmark SPY, which returned +4.73% annual.
Over the past 5 years, SGTX has had an average annual return of -56.77%, underperforming the benchmark SPY, which returned +4.12% annual.
Since Dec 4, 2020, SGTX has had an average annual return of -67.31%, underperforming the benchmark SPY, which returned +8.85% annual.
| 2023 | 2022 | 2021 | 2020 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +392.08% | -87.28% | -94.25% | +38.10% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +105.94% | +50.48% | -14.70% | -21.35% | -55.71% | +435.48% | -7.03% | +7.34% | +392.08% | ||||
| 2022 | -29.35% | -25.67% | +1.44% | -28.61% | -27.81% | +9.63% | -14.64% | -12.25% | -18.99% | -0.69% | -21.53% | -10.62% | -87.28% |
| 2021 | -36.27% | -13.10% | -15.98% | -37.80% | -16.06% | -8.05% | -53.03% | +17.87% | -4.92% | -4.56% | -30.26% | -26.55% | -94.25% |
| 2020 | +38.10% | +38.10% |
Drawdown analysis of Sigilon Therapeutics (SGTX)
The maximum drawdown for the SGTX was -99.39%, occurring on Dec 27, 2022. This drawdown has not yet recovered.
The current SGTX drawdown is -96.40%.
Since Dec 4, 2020 SGTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.39% | Dec 31, 2020 | 500 | Dec 27, 2022 | Ongoing | Ongoing | Ongoing |
| -20.64% | Dec 4, 2020 | 5 | Dec 11, 2020 | 6 | Dec 21, 2020 | 11 |
| -17.66% | Dec 22, 2020 | 5 | Dec 30, 2020 | 1 | Dec 31, 2020 | 6 |